COMP <GO>
CORZ vs JPM // RETURN ON INVESTED CAPITAL (ROIC)
Core Scientific Inc. (NASDAQ) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: CORZ 4
— JPM 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: JPM
LAST: $13.25 (-8.18%) • MKT CAP: $4.64B
roic
-35.00%
LAST: $337.04 (-1.90%) • MKT CAP: $895.92B
roic
17.37%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CORZ VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CORZ | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 11.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 17.37% | -52.37 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.72% | -18.14% | +8.42 | CORZ | /fcf-yield <GO> |
| Operating Margin | -60.00% | 42.07% | -102.07 | JPM | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 32.63% | -92.63 | JPM | /net-margins <GO> |
| Revenue Growth (YoY) | -37.50% | 13.53% | -51.03 | JPM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.96% | -1.96 | JPM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.37 | +0.08 | CORZ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 2/9 | +3.00 | CORZ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 4.84% | +2.46 | JPM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.0 | 49.0 | -10.01 | JPM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.12 | 1.00 | +0.12 | CORZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 13.6x | +15.43 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.64B | $895.92B | -$891.28B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CORZ REV | JPM REV | CORZ GROSS % | JPM GROSS % | CORZ FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $319.0M | $182.45B | 11.9% | — | -$450.8M | -$147.78B |
| FY 2024 | $510.7M | $177.56B | 23.7% | — | -$52.1M | -$42.01B |
| FY 2023 | $502.4M | $158.10B | 44.0% | — | $42.5M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CORZ // BETA 1.12
JPM // BETA 1.00